← Back to headlines
Eton Pharmaceuticals Shares Jump on Strong Q2 Results and 2026 Guidance
Eton Pharmaceuticals saw its shares rise following a strong second-quarter earnings report and positive guidance for 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
